Leukocyte recruitment at sites of tumor: Dissonant orchestration

Journal of Leukocyte Biology

Volumn 70, Issue 2, 2001, Pages 171-184

  Carlos, T M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Chemokine; Cytokine; Immunotherapy

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; PADGEM PROTEIN; RECOMBINANT INTERLEUKIN 2; VASCULAR ADHESION PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL MODEL; BINDING SITE; CANCER IMMUNOTHERAPY; CELL ADHESION; CELL INFILTRATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR BIOPSY; TUMOR LOCALIZATION; WOUND HEALING;

ANIMALS; CELL ADHESION MOLECULES; CHEMOTAXIS, LEUKOCYTE; HUMANS; IMMUNOTHERAPY; INFLAMMATION; INTERLEUKIN-2; NEOPLASMS;

ANIMALIA;

EID: 0034880545     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (161)

1. Interleukin-2 for treatment of advanced melanoma
2. Results of interleukin-2-based treatment in advanced melanoma: A case record-based analysis of 631 patients
3. Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma
4. Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
5. The immunopathology of sequential tumor biopsies in patients treated with interleukin-2: Correlation of response with T cell infiltration and HLA-DR expression
6. Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans
7. Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes
8. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
9. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
10. Mechanisms of tumour metastasis
11. Sticky and smelly issues: Lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer
12. Tumor-induced immune dysfunction
13. Signaling defects in T lymphocytes of patients with malignancy
14. Structure and function of the leukocyte adhesion molecules CD11/CD18
15. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3
16. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions
17. Expression of α4-integrins on human neutrophils
18. Selective expression of integrin α4β7 on a subset of human CD4+ memory T cells with hallmarks of gut-trophism
19. Expression and function of the MAdCAM-1 receptor, integrin α1β7, on human leukocytes
20. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells
21. P-selectin glycoprotein lignad-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin
22. Role of PSGL-1 binding to selectins in leukocyte recruitment
23. Regulation and lectin activity of the human neutrophil peripheral lymph node homing receptor
24. Selectin ligands: Will the real ones please stand up?
25. The α(1, 3) fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand synthesis
26. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites
27. α(1, 3)-Fucosyltransferase VII and α(2, 3)-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites
28. x determinant, a ligand for E-and P-selectin
29. Molecular characterization and functional analysis of the leukocyte surface protein CD31
30. Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family
31. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion
32. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73)
33. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium
34. Regulation of leukocyte integrin function: Affinity vs avidity
35. T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1
36. 2 functions
37. 1 integrindependent cell adhesion is regulated by a low affinity receptor pool that is conformationally responsive to ligand
38. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors
39. Identification of a human peripheral lymph node homing receptor: A rapidly down-regulated adhesion molecule
40. In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions
41. Leukocyte activation induces surface redistribution of P-selectin glycoprotein ligand-1
42. Chemokines-chemotactic cytokines that mediate inflammation
43. Key role of chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease
44. Chemokine receptors and their role in inflammation and infectious diseases
45. Induction by IL-1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)
46. The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines
47. Characterization of ICAM-2 and evidence for a third counterreceptor for LFA-1
48. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule
49. The Weibel-Palade Body: The storage granule for von Willebrand factor and P-selectin
50. Identification of an inducible endothelial-leukocyte adhesion molecule
51. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokineactivated cultured human endothelial cells
52. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans
53. Induction and function of vascular cell adhesion molecule-1 at sites of inflammation
54. Vascular adhesion protein-1 (VAP-1) mediates lymphocyte subtypespecific, selectin-independent recognition of vascular endothelium in human lymph nodes
55. TNF-α, IL-4, and IFN-γ regulate differential expression of P- and E-selectin by porcine aortic endothelial cells
56. IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro
57. Vascular endothelial platelet cell adhesion molecule-1 (PECAM-1) expression is decreased by TNF-α and IFN-γ: Evidence for cytokine-induced destabilization of messenger ribonucleic acid transcripts in bovine endothelial cells
58. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-α and IFN-γ
59. IFN-γ inhibits activation-induced expression of E- and P-selectin on endothelial cells
60. IL-4 decreases IFN-gamma-induced endothelial ICAM-1 expression by a transcriptional mechanism
61. IL-4 regulates endothelial activation by IL-1, tumor necrosis factor or IFN-γ
62. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial adhesiveness for T cells: The contribution of vascular cell adhesion molecule-dependent and -independent binding mechanisms
63. Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells
64. IL-10 inhibits the adhesion of leukocytic cells to IL-1 activated human endothelial cells
65. Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis
66. Transforming growth factor-b inhibits E-selectin expression on human endothelial cells
67. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium
68. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors
69. The origin and function of tumor-associated macrophages
70. Role of nitric oxide in angiogenesis and microcirculation in tumors
71. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1
72. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
73. A central role for microvillous receptor presentation in leukocyte adhesion under flow
74. 4-integrin support leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo
75. The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: Their quantitative definition and relation to leukocyte dysfunction and clinical features
76. Brief report: Recurrent severe infections caused by a novel leukocyte adhesion deficiency
77. Spontaneous skin ulceration and defective T cell function in CD18 null mice
78. 2 integrin leukocyte function-associated antigen-1
79. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice
80. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice
81. Loss of endothelial surface expression of E-selectin in a patient with recurrent infections
82. Characterization of E-selectindeficient mice: Demonstration of overlapping function of the endothelial selectins
83. Leukocyte rolling and extravasation are severely compromised in P-selectin-deficient mice
84. Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin
85. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule-1
86. Prolonged eosinophil accumulation in allergic lung interstitium of ICAM-2-deficient mice results in extended hyperresponsiveness
87. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions
88. Targeted disruption of the murine VCAM-1 gene: Essential role of VCAM-1 in chorioallantoic fusion and placentation
89. The mononuclear-cell response to injury
90. The in vivo quantitation and kinetics of rabbit neutrophil leukocyte accumulation in the skin in response to chemotactic agents and Escherichia coli
91. Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat
92. Kinetic expression of endothelial adhesion molecules and relationship to leukocyte recruitment in two cutaneous models of inflammation
93. The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissues
94. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1α, tumor necrosis factor-α, and IFN-γ
95. Monocyte retention and migration in pulmonary inflammation: Requirement of neutrophils
96. Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia
97. Focal effects of mononuclear leukocyte transendothelial migration: TNF-α production by migrating monocytes promotes subsequent migration of lymphocytes
98. TNF-α released by comigrating monocytes promotes transendothelial migration of activated lymphocytes
99. Activation of human monocytes for enhanced production of interleukin 8 during transendothelial migration in vitro
100. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro
101. Wound repair: Overview and general considerations
102. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: Prolonged persistence of neutrophils and macrophages during the late phase of repair
103. Role of endothelial selectins in wound repair
104. Modulation of JE/MCP-1 expression in dermal wound repair
105. MIP-1α as a critical macrophage chemoattractant in murine wound repair
106. Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing
107. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing
108. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
109. Diminished leukocyte-endothelial interaction in tumor microvessels
110. Tumor necrosis factor-α-induced leukocyte adhesion in normal and tumor vessels: Effects of tumor type, transplantation site, and host strain
111. Leukocyte adhesion in angiogenic blood vessels: Role of E-selectin, P-selectin, and β2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels
112. NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction
113. Enhanced induction of very late activation antigen 4/lymphocyte function-associated antigen-1-dependent T cell migration to tumor sites following administration of interleukin 12
114. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor
115. Treatment of murine gliomas with adoptive transfer of ex vivo activated tumor-draining lymph node cells
116. Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires downregulation of L-selectin expression
117. low cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes
118. Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cells
119. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes
120. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors
121. Expression of selectin ligands by cutaneous squamous cell carcinoma
122. Lymphocyte-endothelial adhesion molecules at the primary tumor site in human lung and renal cell carcinomas
123. Cytokine production and expression of adhesion molecules and integrins in tumor-infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung
124. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumor necrosis factor alpha (rTNFα)
125. Cell adhesion molecule expression within the microvasculature of human colorectal malignancies
126. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and ER-selectin on intratumoral vessels
127. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium
128. Expression of adhesion molecules in the host response to colon carcinoma
129. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer
130. Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma
131. Intercellular adhesion molecule-3 on endothelial cells: Expression in tumors but not in inflammatory responses
132. Transient induction of E-selectin expression following TNFα-based isolated limb perfusion in melanoma and sarcoma patients is not tumor specific
133. Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: A role for tumor-cell-secreted interleukin-1α
134. Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis
135. Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer
136. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumorinfiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma
137. Lack of expression of endothelial adhesion molecules at sites of melanoma metastases in humans
138. Endothelial vascular cell adhesion molecule-1 expression is suppressed by melanoma and carcinoma
139. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: The role of angiogenic factors
140. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium
141. Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer
142. Local expression of anti-inflammatory cytokines in cancer
143. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes
144. Cytokine gene transcription in renal cell carcinoma
145. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes
146. Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma
147. Human non-small cell lung cancer cells express a type 2 cytokine pattern
148. Cytokine production and expression of adhesion molecules and integrins in tumor infiltrating lymphomononuclear cells of non-small cell carcinomas of the lung
149. Expression and cytokine-modulation of endothelial adhesion molecules in murine melanoma
150. Dermatologic changes associated with interleukin 2 administration
151. Endothelial activation during interleukin 2 immunotherapya possible mechanism for vascular leak syndrome
152. Immunopathological changes in the skin following recombinant interleukin-2 treatment
153. Adhesion molecule expression and leucocyte trafficking following immunotherapy with recombinant interleukin-2
154. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration
155. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression of leukocyte rolling
156. Effects of intravenous IL-8 administration in nonhuman primates
157. Inhibition of leukocyte emigration induced during the systemic inflammatory reaction in vivo in not due to IL-8
158. Antagonistic effects of systemic interleukin 2 on immune T cell-mediated graft-versusleukemia reactivity
159. Unique characteristics associated with systemic adoptive immunotherapy of experimental intracerebral tumors
160. Local versus systemic interleukin-2: Tumor formation by wild-type and B7-1-positive murine melanoma cells
161. The intriguing role of polymorphonuclear neutrophils in antitumor reactions